RFX6 facilitates aerobic glycolysis‐mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1
Authors:
Open Access
- 13 December 2023
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 13 (12) , e1511
Abstract
Background: Hepatocellular carcinoma (HCC) cells undergo reprogramming of glucose metabolism to support uncontrolled proliferation, of which the intrinsic mechanism still merits further investigation. Although regulatory factor X6 (RFX6) is aberrantly expressed in different cancers, its precise role in cancer development remains ambiguous.Methods: Microarrays of HCC tissues were employed to investigate the expression of RFX6 in tumour and adjacent non‐neoplastic tissues. Functional assays were employed to explore the role of RFX6 in HCC development. Chromatin immunoprecipitation, untargeted metabolome profiling and sequencing were performed to identify potential downstream genes and pathways regulated by RFX6. Metabolic assays were employed to investigate the effect of RFX6 on glycolysis in HCC cells. Bioinformatics databases were used to validate the above findings.Results: HCC tissues exhibited elevated expression of RFX6. High RFX6 expression represented as an independent hazard factor correlated to poor prognosis in patients with HCC. RFX6 deficiency inhibited HCC development in vitro and in vivo, while its overexpression exerted opposite functions. Mechanistically, RFX6 bound to the promoter area of phosphoglycerate mutase 1 (PGAM1) and upregulated its expression. The increased PGAM1 protein levels enhanced glycolysis and further promoted the development of HCC.Conclusions: RFX6 acted as a novel driver for HCC development by promoting aerobic glycolysis, disclosing the potential of the RFX6–PGAM1 axis for therapeutic targeting.Keywords
Funding Information
- National Natural Science Foundation of China (81372571, 81902473)
This publication has 52 references indexed in Scilit:
- Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese populationNature Genetics, 2010
- Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinomaMolecular Cancer, 2010
- Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinomaBMC Cancer, 2010
- Rfx6 directs islet formation and insulin production in mice and humansNature, 2010
- Rfx6 is an Ngn3-dependent winged helix transcription factor required for pancreatic islet cell developmentDevelopment, 2010
- Novel roles for GAPDH in cell death and carcinogenesisCell Death & Differentiation, 2009
- Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular CarcinomaGastroenterology, 2008
- Identification and characterization of novel human tissue-specific RFX transcription factorsBMC Ecology and Evolution, 2008
- Resveratrol-induced cell growth inhibition and apoptosis is associated with modulation of phosphoglycerate mutase B in human prostate cancer cells: two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry evaluationCancer Detection Prevention, 2004
- THE METABOLISM OF TUMORS IN THE BODYJournal of General Physiology, 1927